Effects of diazoxide, clonidine and a new alpha-blocking agent on renal clearances.
D000959:Antihypertensive Agents / Q000009:adverse effects / Q000494:pharmacology*; D003000:Clonidine / Q000494:pharmacology*; D003981:Diazoxide / Q000494:pharmacology*; D005919:Glomerular Filtration Rate; D006801:Humans; D007024:Hypotension, Orthostatic / Q000139:chemically induced; D007457:Iodine Radioisotopes; D007465:Iodohippuric Acid; D007483:Iothalamic Acid; D007668:Kidney / Q000187:drug effects*; D007677:Kidney Function Tests; D008297:Male; D008875:Middle Aged; D009281:Naphthalenes / Q000494:pharmacology; D010080:Oxazoles / Q000009:adverse effects / Q000494:pharmacology*; D010880:Piperidines / Q000009:adverse effects / Q000494:pharmacology*; D011674:Pulse / Q000187:drug effects; D013141:Spiro Compounds / Q000009:adverse effects / Q000494:pharmacology
D000959:Antihypertensive Agents; D007457:Iodine Radioisotopes; D009281:Naphthalenes; D010080:Oxazoles; D010880:Piperidines; D013141:Spiro Compounds; D007465:Iodohippuric Acid; D007483:Iothalamic Acid; D003000:Clonidine; D003981:Diazoxide